More than 200 preventive vaccines, developed by both industry and non-industry players

Technical advances, especially in the field of biotechnology, have led to the development of several next generation preventive vaccines, including recombinant vaccines, viral vector based vaccines and DNA vaccines, which have been demonstrated to elicit powerful immune responses, resulting in the development of immunological memory.

To order this 250+ page report, which features 85+ figures and 125+ tables, please visit this –

https://www.rootsanalysis.com/reports/view_document/preventive-vaccines/318.html

The USD 94 billion (by 2030) financial opportunity within the global preventive vaccine market has been analyzed across the following segments:

• Route of Administration
• Intramuscular
• Subcutaneous
• Oral
• Intravenous
• Others

• Type of Vaccine
• Pneumococcal Conjugate Vaccine
• Human Papilloma Virus Vaccine
• Rotavirus Vaccine
• Influenza Vaccine
• MMR Vaccine
• Tetanus and Diphtheria Booster Vaccine
• Varicella Vaccine
• DTaP-Hib-IPV Vaccine
• DTaP-HepB-Hib-IPV Vaccine
• Others

• Type of Vaccine API
• Live, Attenuated Vaccine
• Inactivated Vaccine
• Conjugate Vaccine
• Subunit Vaccine
• Toxoid Vaccine
• Others

• Target Patient Population
• Pediatric Patients
• Adults

• Key Players
• GlaxoSmithKline
• Merck
• Sanofi Pasteur
• Pfizer
• Emergent BioSolutions
• CSL
• Others

• Key Geographical Regions 
• North America
• Europe
• Asia Pacific
• Rest of the World 

The Global Preventive Vaccines Market, 2020-2030 report features the following companies, which we identified to be key players in this domain:

• Bio Farma
• Emergent BioSolutions
• GC Pharma
• GlaxoSmithKline
• Janssen
• Merck
• Novavax
• Pfizer
• Sanofi Pasteur
• Valneva

To request for sample report - https://www.rootsanalysis.com/reports/318/request-sample.html

Table of Contents

1. Preface
   
   2. Executive Summary
2. 
   Introduction
   
3. Market Landscape
   
4. Company Competitiveness Analysis
   
5. Company Profiles
   
6. Clinical Trial Analysis
   
7. Ongoing Vaccine Development Initiatives for Complex Conditions
   
8. Funding and Investment Analysis
   
9. Market Sizing and Opportunity Analysis
   
10. Case-in-Point: Contract Manufacturing of Vaccines
    
11. Concluding Remarks

13. Executive Insights

14. Appendix 1: Tabulated Data

15. Appendix 2: List of Companies and Organizations

Other Recent Offerings:

1. Antibody Drug Conjugates Market (5th Edition), 2019-2030
2. Gene Therapy Market (3rd Edition), 2019 - 2030
3. Global T-Cell (CAR-T, TCR, and TIL) Therapy Market (4th Edition), 2019 – 2030
4. Synthetic Lethality-based Drugs and Targets Market, 2019-2030

To purchase a copy, please visit https://www.rootsanalysis.com/reports/view_document/preventive-vaccines/318.html

About Roots Analysis

Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com

Contact Information

Roots Analysis Private Limited

Gaurav Chaudhary

+1 (415) 800 3415

ben.johnson@rootsanalysis.com

Facebook - https://www.facebook.com/RootsAnalysis

LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/

Twitter - https://twitter.com/RootsAnalysis